PMD Psychemedics Corp.

Psychemedics Corporation Launches New Ketamine Hair Testing Service

Psychemedics Corporation Launches New Ketamine Hair Testing Service

DALLAS, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing, is proud to announce the launch of its new ketamine hair testing solution. This innovative testing method marks a significant advancement in the detection and prevention for a drug-free workplace and community.

Ketamine, a powerful dissociative anesthetic and emerging drug of abuse, poses a growing concern for employers, educators, and law enforcement agencies. With the introduction of this new testing service, Psychemedics aims to equip organizations with the tools needed to identify and address ketamine use effectively.

Key Features and Benefits of Ketamine Hair Testing

  1. Long Detection Window: Unlike traditional drug testing methods, hair analysis can detect ketamine use for up to 90 days, providing a comprehensive overview of an individual’s drug use history.
  2. Non-Invasive and Convenient: The hair collection process is simple and noninvasive and can be performed without the need for specialized facilities, making it ideal for various testing environments.
  3. High Sensitivity and Specificity: Utilizing advanced technology, Psychemedics’ ketamine hair test ensures highly accurate results, minimizing the risk of false positives and negatives.
  4. Comprehensive Drug Panel: This new service can be integrated into existing multi-drug panels offered by Psychemedics, allowing for a broad-spectrum approach to drug testing.
  5. Support for Various Industries: The ketamine hair test is designed to meet the needs of diverse sectors, including workplace safety programs, educational institutions, rehabilitation centers, law enforcement agencies, and many others.

“We are thrilled to introduce ketamine hair testing as part of our commitment to delivering the most reliable and comprehensive drug testing solutions,” said Brian Hullinger, CEO and President of Psychemedics. “This new offering underscores our dedication to innovation and our mission to support organizations in maintaining safe and drug-free environments.”

Psychemedics’ ketamine hair testing service is now available to clients and partners. For more information about this new service or to schedule a consultation, please contact Psychemedics at or visit our website at .

About Psychemedics 

Psychemedics Corporation is a leading global provider of innovative hair testing for drugs of abuse. With a commitment to accuracy and reliability, the company offers cutting-edge drug testing solutions. Psychemedics Corporation is dedicated to providing valuable insights and maintaining the highest standards in substance abuse testing.

Investor Relations:

Phone: 978-206-8220

Email:  



EN
29/08/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Psychemedics Corp.

 PRESS RELEASE

Psychemedics Releases First-Ever Education Insights Report: Uncovering...

Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing DALLAS, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing for drugs of abuse, is excited to announce the release of its first-ever Education Insights Report. This report provides an in-depth analysis of drug trends within educational institutions, shedding light on the growing challenges schools face in maintaining a drug-free environment for students and staff. Following the success of our inaugur...

 PRESS RELEASE

Psychemedics Corporation Launches New Ketamine Hair Testing Service

Psychemedics Corporation Launches New Ketamine Hair Testing Service DALLAS, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing, is proud to announce the launch of its new ketamine hair testing solution. This innovative testing method marks a significant advancement in the detection and prevention for a drug-free workplace and community. Ketamine, a powerful dissociative anesthetic and emerging drug of abuse, poses a growing concern for employers, educators, and law enforcement agencies. With the introduction of this new tes...

 PRESS RELEASE

Psychemedics Corporation Reports Second Quarter 2024 Financial Results

Psychemedics Corporation Reports Second Quarter 2024 Financial Results DALLAS, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s leading provider of hair testing for drugs of abuse, today announced financial results for the second quarter ending June 30, 2024. The Company’s revenue for three months ended June 30, 2024, was $4.7 million versus $5.5 million for three months ended June 30, 2023, a decrease of 15%. Net loss was $0.8 million, or $0.14 per share, compared to a net loss of $0.7 million, or $0.13 per share, for the three months ended June 2024...

 PRESS RELEASE

Psychemedics Corporation’s Board of Directors Approves Plan to Termina...

Psychemedics Corporation’s Board of Directors Approves Plan to Terminate Registration of Its Common Stock DALLAS, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (Nasdaq:PMD) (“Psychemedics” or the “Company”) today announced that a Transaction Committee (the “Transaction Committee”) of the Board of Directors of the Company (the “Board”) comprised of independent directors has recommended, and the Board has approved, a plan to cease the registration of the Company’s common stock under the federal securities laws following the completion of a proposed reverse stock split and to de...

 PRESS RELEASE

Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends ...

Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair Testing DALLAS, June 21, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing for drugs of abuse, proudly presents its inaugural Insights Report. This groundbreaking report offers a comprehensive analysis of drug trends in the workplace, drawing insights from a vast dataset of hair samples collected and analyzed in 2023. As pioneers in the field of hair testing, Psychemedics collected hundreds of thousands of hair samples from individuals across diverse industrie...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch